Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CARES (Contrast EchocArdiography REgistry for Safety Surveillance): A Prospective, Phase IV, Open-Label, Nonrandomized, Multicenter, Surveillance Registry Study to Evaluate the Safety of DEFINITY® in Clinical Practice

NCT00625365 is registered in ClinicalTrials.gov with Lantheus Medical Imaging as lead sponsor.

NCT NCT00625365
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00625365 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CARES (Contrast EchocArdiography REgistry for Safety Surveillance): A Prospective, Phase IV, Open-Label, Nonrandomized, Multicenter, Surveillance Registry Study to Evaluate the Safety of DEFINITY® in Clinical Practice
Lead sponsor
Lantheus Medical Imaging
Phase
Phase 4
Overall status
Completed
Start date
February 29, 2008
Completion date
July 31, 2009
Enrollment
1,060 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular disease